Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

I have been incorporating the Sherak Reactivation Serum into my daily regimen for a few weeks now to see how their ...

Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

A weekly newsletter focusing on the most important news in health and biotech. Founded at the Massachusetts Institute of ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

By Deena Beasley SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials than the U.S., still lags in the quality and commercial reach of its biomedical science, according ...

The Fidelity Select Biotechnology Portfolio invests in companies engaged in the research, manufacturing and distribution of biotech and related products. The fund invests in the common stocks of these ...

Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date - Dose-dependent anti-tumo ...